Literature DB >> 9860927

The aryl hydrocarbon receptor: studies using the AHR-null mice.

F J Gonzalez1, P Fernandez-Salguero.   

Abstract

The aryl hydrocarbon receptor (AHR) is believed to mediate the toxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), polychlorinated biphenyls, and polycyclic aromatic hydrocarbons. AHR is a member of the Per, ARNT, Sim/basic-helix-loop-helix superfamily of ligand-activated transcription factors that also harbors the transcription factors involved in the hypoxia response, development of the central nervous system, and day-night adaptations. To investigate the role of AHR in chemical toxicity and carcinogenesis and to determine any possible function in mammalian development and physiological homeostasis, AHR-null mice were developed. The AHR-null mice were resistant to the acute toxicity of TCDD and had an altered teratogenic response to this compound. These mice were found to have a number of abnormal phenotypes, thus confirming that AHR plays an important developmental and physiological role. Among the most consistent phenotypes was an altered liver pathology that was associated with accelerated rates of apoptosis. Evidence suggests that this may be related to an abnormal accumulation of levels of hepatic retinoic acid that cause an activation of transforming growth factor beta, resulting in stimulation of apoptosis. AHR may directly or indirectly control levels of a cytochrome P450 that is responsible for catabolizing retinoic acid.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9860927

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  83 in total

1.  Activation of the aryl hydrocarbon receptor during pregnancy in the mouse alters mammary development through direct effects on stromal and epithelial tissues.

Authors:  Betina J Lew; Ravikumar Manickam; B Paige Lawrence
Journal:  Biol Reprod       Date:  2011-01-26       Impact factor: 4.285

2.  Comparisons of differential gene expression elicited by TCDD, PCB126, βNF, or ICZ in mouse hepatoma Hepa1c1c7 cells and C57BL/6 mouse liver.

Authors:  Rance Nault; Agnes L Forgacs; Edward Dere; Timothy R Zacharewski
Journal:  Toxicol Lett       Date:  2013-08-29       Impact factor: 4.372

Review 3.  RelB: an outlier in leukocyte biology.

Authors:  Patrick Millet; Charles McCall; Barbra Yoza
Journal:  J Leukoc Biol       Date:  2013-08-06       Impact factor: 4.962

4.  Ube2l3 gene expression is modulated by activation of the aryl hydrocarbon receptor: implications for p53 ubiquitination.

Authors:  O D Reyes-Hernández; A Mejía-García; E M Sánchez-Ocampo; M A Cabañas-Cortés; P Ramírez; L Chávez-González; F J Gonzalez; G Elizondo
Journal:  Biochem Pharmacol       Date:  2010-05-15       Impact factor: 5.858

5.  Alteration of the 4-sphingenine scaffolds of ceramides in keratinocyte-specific Arnt-deficient mice affects skin barrier function.

Authors:  Satoshi Takagi; Hiromasa Tojo; Shuhei Tomita; Shigetoshi Sano; Satoshi Itami; Mariko Hara; Shintaro Inoue; Kyoji Horie; Gen Kondoh; Ko Hosokawa; Frank J Gonzalez; Junji Takeda
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 6.  A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family.

Authors:  Christoph F A Vogel; Fumio Matsumura
Journal:  Biochem Pharmacol       Date:  2008-10-08       Impact factor: 5.858

Review 7.  The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways.

Authors:  Alvaro Puga; Ci Ma; Jennifer L Marlowe
Journal:  Biochem Pharmacol       Date:  2008-09-05       Impact factor: 5.858

8.  Retinoic acid modulates retinaldehyde dehydrogenase 1 gene expression through the induction of GADD153-C/EBPbeta interaction.

Authors:  Guillermo Elizondo; Irma M Medina-Díaz; Raymundo Cruz; Frank J Gonzalez; Libia Vega
Journal:  Biochem Pharmacol       Date:  2008-10-17       Impact factor: 5.858

9.  Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators.

Authors:  Carolyn D DuSell; Erik R Nelson; Bryan M Wittmann; Jackie A Fretz; Dmitri Kazmin; Russell S Thomas; J Wesley Pike; Donald P McDonnell
Journal:  Mol Endocrinol       Date:  2009-11-09

10.  The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy.

Authors:  Shu Zhang; Ping Lei; Xinyi Liu; Xiangrong Li; Kelcey Walker; Leela Kotha; Craig Rowlands; Stephen Safe
Journal:  Endocr Relat Cancer       Date:  2009-05-15       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.